Literature DB >> 25824815

Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence.

Crystal L Jones1, Megan Clancy2, Cary Honnold3, Shweta Singh1, Erik Snesrud4, Fatma Onmus-Leone4, Patrick McGann4, Ana C Ong4, Yoon Kwak4, Paige Waterman4, Daniel V Zurawski1, Robert J Clifford4, Emil Lesho4.   

Abstract

BACKGROUND: Severe Acinetobacter baumannii infections in immunocompetent patients are uncommon, and the virulence mechanisms of this organism are not fully understood.
METHODS: Following an outbreak of fatal A. baumannii infections in a cohort of relatively immunocompetent patients (low comorbidity and illness severity scores), isolates were investigated with comparative genomics and in animal models.
RESULTS: Two unrelated A. baumannii clades were associated with the outbreak. The clone associated with the majority of patient deaths, clade B, is evolutionarily distinct from the 3 international clonal complexes, belongs to multilocus sequence type (MLST) 10, and is most closely related to strains isolated from the Czech Republic, California, and Germany in 1994, 1997, and 2003, respectively. In 2 different murine models, clade B isolates were more virulent than comparator strains, including the highly virulent reference strain AB5075. The most virulent clade B derivative, MRSN 16897, was isolated from the patient with the lowest combined comorbidity/illness severity score. Clade B isolates possess a unique combination of putative virulence genes involved in iron metabolism, protein secretion, and glycosylation, which was leveraged to develop a rapid and specific clinical assay to detect this clade that cannot be distinguished by MLST.
CONCLUSIONS: Clade B warrants continued surveillance and investigation. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Acinetobacter baumannii; extensively drug resistant; outbreak; virulence

Mesh:

Year:  2015        PMID: 25824815     DOI: 10.1093/cid/civ225

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  33 in total

1.  Next-Generation Sequencing and Comparative Analysis of Sequential Outbreaks Caused by Multidrug-Resistant Acinetobacter baumannii at a Large Academic Burn Center.

Authors:  Hajime Kanamori; Christian M Parobek; David J Weber; David van Duin; William A Rutala; Bruce A Cairns; Jonathan J Juliano
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

2.  Structural Diversity in the Type IV Pili of Multidrug-resistant Acinetobacter.

Authors:  Kurt H Piepenbrink; Erik Lillehoj; Christian M Harding; Jason W Labonte; Xiaotong Zuo; Chelsea A Rapp; Robert S Munson; Simeon E Goldblum; Mario F Feldman; Jeffrey J Gray; Eric J Sundberg
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

Review 3.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 4.  Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.

Authors:  Edward Geisinger; Ralph R Isberg
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

5.  Exposure to dairy manure leads to greater antibiotic resistance and increased mass-specific respiration in soil microbial communities.

Authors:  Carl Wepking; Bethany Avera; Brian Badgley; John E Barrett; Josh Franklin; Katharine F Knowlton; Partha P Ray; Crystal Smitherman; Michael S Strickland
Journal:  Proc Biol Sci       Date:  2017-03-29       Impact factor: 5.349

6.  Prevalence of Acinetobacter baumannii strains expressing the Type 6 secretion system in patients with bacteremia.

Authors:  Guillermo D Repizo
Journal:  Virulence       Date:  2017-06-26       Impact factor: 5.882

7.  Analysis of drug resistance in 1,861 strains of Acinetobacter baumannii.

Authors:  Hao Jin; Fan Qiu; Hong Jian Ji; Qiang Lu
Journal:  Biomed Rep       Date:  2016-02-15

8.  A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit.

Authors:  Marianna Meschiari; José-María Lòpez-Lozano; Vincenzo Di Pilato; Carola Gimenez-Esparza; Elena Vecchi; Erica Bacca; Gabriella Orlando; Erica Franceschini; Mario Sarti; Monica Pecorari; Antonella Grottola; Claudia Venturelli; Stefano Busani; Lucia Serio; Massimo Girardis; Gian Maria Rossolini; Inge C Gyssens; Dominique L Monnet; Cristina Mussini
Journal:  Antimicrob Resist Infect Control       Date:  2021-08-19       Impact factor: 4.887

9.  Differential Role of the T6SS in Acinetobacter baumannii Virulence.

Authors:  Guillermo D Repizo; Stéphanie Gagné; Marie-Laure Foucault-Grunenwald; Vitor Borges; Xavier Charpentier; Adriana S Limansky; João Paulo Gomes; Alejandro M Viale; Suzana P Salcedo
Journal:  PLoS One       Date:  2015-09-24       Impact factor: 3.240

10.  Risk factors for mortality in ICU patients with Acinetobacter baumannii ventilator-associated pneumonia: impact of bacterial cytotoxicity.

Authors:  Mohan Ju; Dongni Hou; Shu Chen; Ying Wang; Xinjun Tang; Jie Liu; Cuicui Chen; Yuanlin Song; Huayin Li
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.